Answers are grounded in this paper and cite their sources.
Collectively, the data suggest that 100% TCJ reduces sUA concentrations, mitigating hyperuricemia associated with gouty arthritis. This trial was registered at clinicaltrials.gov as NCT03636529.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: